The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis
Abstract
Mouse models of the GM2 gangliosidoses [Tay-Sachs, late onset Tay-Sachs (LOTS), Sandhoff] and GM1 gangliosidosis have been studied to determine whether there is a common neuro-inflammatory component to these disorders. During the disease course, we have: (i) examined the expression of a number of inflammatory markers in the CNS, including MHC class II, CD68, CD11b (CR3), 7/4, F4/80, nitrotyrosine, CD4 and CD8; (ii) profiled cytokine production [tumour necrosis factor alpha (TNF alpha), transforming growth factor (TGF beta 1) and interleukin 1 beta (IL1 beta)]; and (iii) studied blood-brain barrier (BBB) integrity. The kinetics of apoptosis and the expression of Fas and TNF-R1 were also assessed. In all symptomatic mouse models, a progressive increase in local microglial activation/expansion and infiltration of inflammatory cells was noted. Altered BBB permeability was evident in Sandhoff and GM1 mice, but absent in LOTS mice. Progressive CNS inflammation coincided with the onset of clinical signs in these mouse models. Substrate reduction therapy in the Sandhoff mouse model slowed the rate of accumulation of glycosphingolipids in the CNS, thus delaying the onset of the inflammatory process and disease pathogenesis. These data suggest that inflammation may play an important role in the pathogenesis of the gangliosidoses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY
MCLEAN, I. W., & NAKANE, P. K. (1974) · Journal of Histochemistry & Cytochemistry · doi:10.1177/22.12.1077 · Cited by 3,798
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 1×
“Normally, apoptotic cells are rapidly cleared without causing an in¯ammatory response (Fadok et al., 1998; Volbracht et al., 1999).”
BackgroundPerry, V. H., Hume, D. A., & Gordon, S. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90215-5 · Cited by 902
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed · Cited by 660
Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468 · cited 4×
“Material and methods Mice Tay-Sachs (Hexa±/±) and Sandhoff (Hexb±/±) mice (Yamanaka et al., 1994; Sango et al., 1995; Taniike et al., 1995; Phaneuf et al., 1996) were provided by Dr Richard Proia (National Institutes of Health, Bethesda, MD, USA).”
BackgroundMethodInfluentialWada, R., Tifft, C. J., & Proia, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10954 · Cited by 403
Chapter 15 Nitric oxide in neurodegeneration
(1998) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63210-0 · Cited by 372
Suzuki, K. (1998) · Neurochemical Research · doi:10.1023/a:1022436928925 · Cited by 281
Itagaki, S., McGeer, P. L., & Akiyama, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90690-8 · Cited by 271 · cited 2×
“MHC class II is rarely expressed in healthy brain tissue, but is heavily expressed by microglial cells following in¯ammatory stimuli or during neurodegenerative processes such as those seen with Alzheimer's disease (Itagaki et al., 1988; Martiney et al., 1998; Perry et al., 1998).”
Background
Cited by
Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Neufeld, E. F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 900
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Davidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006951 · Cited by 449
Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
Vitner, E. B., Platt, F. M., & Futerman, A. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.134452 · Cited by 369
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects
Brunetti-Pierri, N., & Scaglia, F. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.04.012 · Cited by 302
Vellodi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05293.x · Cited by 295
Clinical features and molecular genetics of autosomal recessive cerebellar ataxias
Fogel, B. L., & Perlman, S. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70054-6 · Cited by 290
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease
Lee, J.-P., Jeyakumar, M., Gonzalez, R., Takahashi, H., Lee, P.-J., Baek, R. C., Clark, D., Rose, H., Fu, G., Clarke, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1548 · Cited by 287
Self-citationGlycosphingolipids and Neuroinflammation in Parkinson’s Disease
Belarbi, K., Cuvelier, E., Bonte, M.-A., Desplanque, M., Gressier, B., Devos, D., & Chartier-Harlin, M.-C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00408-1 · Cited by 155
Vitner, E. B., Farfel-Becker, T., Eilam, R., Biton, I., & Futerman, A. H. (2012) · Brain · doi:10.1093/brain/aws095 · Cited by 149
Lysosomal multienzyme complex: pros and cons of working together
Bonten, E. J., Annunziata, I., & d’Azzo, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1538-3 · Cited by 117
Self-citationAllende, M. L., Zhu, H., Kono, M., Hoachlander-Hobby, L. E., Huso, V. L., & Proia, R. L. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109879 · Cited by 37
Blood-brain barrier impairment in an animal model of MPS III b
Garbuzova-Davis, S., Louis, M. K., Haller, E. M., Derasari, H. M., Rawls, A. E., & Sanberg, P. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016601 · Cited by 32
Metadata
- Authors
- Jeyakumar, M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 126
- Issue
- 4
- Pages
- 974-987
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2122810522
- Cited by
- 352
- References
- 46
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.